Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who started this subject	5/29/2003 8:50:46 PM
From: mopgcw	Read Replies (1) of 590

The Goldman Sachs Biotechnology Team will host a conference call today, May 29th at 10AM EDT. Maykin Ho, Meg Malloy and Steve McGarry will preview events at the annual meeting of the American Society of Clinical Oncology (ASCO) on May 30 - June 3. The team will highlight presentations by Abgenix, Amgen, Genentech, GPC Biotech, IDEC, MediGene, MedImmune, Millennium and Zeltia. The call is for INSTITUTIONAL INVESTORS only. To participate, please dial 800-203-4101 (US), 952-556-2859 (Int'l). Replay (800) 615-3210 (US), 703-326-3020 (Int'l), 5076453 (passcode).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next